Literature DB >> 8926068

Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia.

J L Burns1, M Jonas, E Y Chi, D K Clark, A Berger, A Griffith.   

Abstract

Pulmonary infections caused by Burkholderia (Pseudomonas) cepacia are an important cause of morbidity and mortality in cystic fibrosis (CF) patients. Several features suggestive of cellular invasion and intracellular sequestration of B. cepacia in CF are persistence of infection in the face of antibiotic therapy to which the organism demonstrates in vitro susceptibility and a propensity to cause bacteremic infections in patients with CF. Epithelial cell invasion was demonstrated in vitro in A549 cells by a modified gentamicin protection assay. The kinetics of invasion appear to be saturable. Electron microscopy of invaded monolayers showed intracytoplasmic bacteria enclosed by membrane-bound vacuoles. No lysosomal fusion with these vacuoles was observed. Intraepithelial cell replication was suggested by electron microscopy and confirmed by both a quantitative assay and a visual assay. Cytochalasin D, but not colchicine, inhibited invasion, suggesting a role for microfilaments but not microtubules. The invasion phenotype in B. cepacia may be an important virulence factor for CF infections.

Entities:  

Mesh:

Year:  1996        PMID: 8926068      PMCID: PMC174336          DOI: 10.1128/iai.64.10.4054-4059.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12.

Authors:  R R Isberg; S Falkow
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

2.  Bordetella parapertussis invasion of HeLa 229 cells and human respiratory epithelial cells in primary culture.

Authors:  C A Ewanowich; R K Sherburne; S F Man; M S Peppler
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

3.  Pneumonia and septicemia due to Pseudomonas cepacia in a patient with cystic fibrosis.

Authors:  B J Rosenstein; D E Hall
Journal:  Johns Hopkins Med J       Date:  1980-11

4.  In vitro model of penetration and intracellular growth of Listeria monocytogenes in the human enterocyte-like cell line Caco-2.

Authors:  J L Gaillard; P Berche; J Mounier; S Richard; P Sansonetti
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

5.  Characterization of Pseudomonas cepacia isolates from patients with cystic fibrosis.

Authors:  A I McKevitt; D E Woods
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

6.  Characterization of hemolysin in extracellular products of Pseudomonas cepacia.

Authors:  T Nakazawa; Y Yamada; M Ishibashi
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

7.  Comparison of the invasion strategies used by Salmonella cholerae-suis, Shigella flexneri and Yersinia enterocolitica to enter cultured animal cells: endosome acidification is not required for bacterial invasion or intracellular replication.

Authors:  B B Finlay; S Falkow
Journal:  Biochimie       Date:  1988-08       Impact factor: 4.079

8.  Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections.

Authors:  G B Pier; M Grout; T S Zaidi; J C Olsen; L G Johnson; J R Yankaskas; J B Goldberg
Journal:  Science       Date:  1996-01-05       Impact factor: 47.728

9.  Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia.

Authors:  R Gold; E Jin; H Levison; A Isles; P C Fleming
Journal:  J Antimicrob Chemother       Date:  1983-07       Impact factor: 5.790

10.  Production of lipase by clinical isolates of Pseudomonas cepacia.

Authors:  M K Lonon; D E Woods; D C Straus
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

View more
  62 in total

1.  Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex.

Authors:  E Mahenthiralingam; T Coenye; J W Chung; D P Speert; J R Govan; P Taylor; P Vandamme
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice.

Authors:  U Sajjan; G Thanassoulis; V Cherapanov; A Lu; C Sjolin; B Steer; Y J Wu; O D Rotstein; G Kent; C McKerlie; J Forstner; G P Downey
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Localization of Burkholderia cepacia complex bacteria in cystic fibrosis lungs and interactions with Pseudomonas aeruginosa in hypoxic mucus.

Authors:  Ute Schwab; Lubna H Abdullah; Olivia S Perlmutt; Daniel Albert; C William Davis; Roland R Arnold; James R Yankaskas; Peter Gilligan; Heiner Neubauer; Scott H Randell; Richard C Boucher
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

Review 4.  Covert operations of uropathogenic Escherichia coli within the urinary tract.

Authors:  Jean M Bower; Danelle S Eto; Matthew A Mulvey
Journal:  Traffic       Date:  2005-01       Impact factor: 6.215

5.  Comparison of antibiotic susceptibility of Burkholderia cepacia complex organisms when grown planktonically or as biofilm in vitro.

Authors:  E Caraher; G Reynolds; P Murphy; S McClean; M Callaghan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-03       Impact factor: 3.267

6.  The posttranscriptional regulator RsmA plays a role in the interaction between Pseudomonas aeruginosa and human airway epithelial cells by positively regulating the type III secretion system.

Authors:  Heidi Mulcahy; Julie O'Callaghan; Eoin P O'Grady; Claire Adams; Fergal O'Gara
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

7.  [Recurrent tonsillopharyngitis associated with Burkholderia cenocepacia : two case reports].

Authors:  A E Zautner; M Krause; G Stropahl; A Podbielski
Journal:  HNO       Date:  2009-05       Impact factor: 1.284

8.  Role of lipase in Burkholderia cepacia complex (Bcc) invasion of lung epithelial cells.

Authors:  T Mullen; K Markey; P Murphy; S McClean; M Callaghan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-12       Impact factor: 3.267

9.  Gentamicin delivery to Burkholderia cepacia group IIIa strains via membrane vesicles from Pseudomonas aeruginosa PAO1.

Authors:  Nick D Allan; Terry J Beveridge
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

10.  A type IV secretion system contributes to intracellular survival and replication of Burkholderia cenocepacia.

Authors:  S Umadevi Sajjan; Lisa A Carmody; Carlos F Gonzalez; John J LiPuma
Journal:  Infect Immun       Date:  2008-09-29       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.